Published: Last Month Price: 1000 to 2500 Category: All Categories Life Sciences Biotechnology Region: All Regions Global -
Global & Czech Republic Cancer Therapeutics Market to 2031
... Therefore, sustained investment in ensuring equitable access to treatment is vital to addressing the ... Read More
-
Global Chromatography Resins Market 2025-2029
... Also, shift towards sustainability and focus on mergers and acquisitions will lead to sizable demand ... Read More
-
Need some help finding the right information ?Verify before you buy
or call us
US toll free: 800.298.5699
Worldwide: +1.240.747.3093
-
Global & Denmark Cancer Therapeutics Market to 2031
... These sustained funding efforts position Denmark as a leader in cancer care innovation, with a focus ... Read More
-
Global Molecular Biology Enzymes, Kits, and Reagents Market 2025-2029
Molecular Biology Enzymes, Kits, And Reagents Market 2025-2029 The molecular biology enzymes, kits, and reagents market is forecasted to grow by USD 10560.9 mn during 2024-2029, accelerating at a CAGR of 9.5% during the forecast period. The report on the molecular biology enzymes, kits, and reagents ... Read More
-
Global & China Cancer Therapeutics Market to 2031
China, one of the world’s most populous nations, is experiencing a significant rise in cancer cases, adding to an already substantial health burden. According to the World Health Organization (WHO), approximately 4.5 million new cancer diagnoses and 3 million cancer-related deaths were reported in t ... Read More
-
Global & Italy Cancer Therapeutics Market to 2031
Italy has seen a steady rise in cancer cases in recent years. Based on GLOBOCAN data from the World Health Organization, approximately 430,000 new cancer cases were reported in the country in 2022, with breast cancer being the most frequently diagnosed, accounting for 13.2% of all cases. This was fo ... Read More
-
Global & Poland Cancer Therapeutics Market to 2031
Poland’s cancer therapeutics market is expanding rapidly, driven by a growing number of cancer cases and ongoing advancements in treatment technologies. Cancer remains one of the leading causes of death in the country. In 2021, the Polish National Cancer Registry reported around 171,558 new cancer d ... Read More
-
Global & Romania Cancer Therapeutics Market to 2031
Romania's cancer therapeutics market is experiencing consistent growth, fueled by a rising number of cancer cases and ongoing advancements in treatment methods. Cancer remains one of the leading causes of mortality in the country, with the Romanian Ministry of Health reporting approximately 100,000 ... Read More
-
Global & Philippines Cancer Therapeutics Market to 2031
The cancer therapeutics market in the Philippines is witnessing growing demand, driven by the introduction of innovative treatments such as targeted therapies, immunotherapies, and biologics. Government efforts, notably through the National Integrated Cancer Control Act and the Philippine Health Ins ... Read More
-
Global & Austria Cancer Therapeutics Market to 2031
According to data released by Statistics Austria in recognition of World Cancer Day (February 4) in 2024, approximately 45,000 people are diagnosed with cancer in Austria each year. This figure is expected to rise to around 50,000 annual cases by 2030. By that same year, the total number of individu ... Read More
-
Global & Brazil Cancer Therapeutics Market to 2031
Cancer is a major chronic health concern among Brazil’s elderly population. As reported by the Pan American Health Organization (PAHO), over 30 million Brazilians were aged 60 and above in 2022, accounting for approximately 13% of the population. This number is projected to increase to nearly 50 mil ... Read More
-
Global & Germany Cancer Therapeutics Market to 2031
Cancer remains a major health challenge in Germany, ranking among the top causes of illness and death. The country reports high incidences of lung, prostate, bladder, colorectal, and skin cancers. Data from the World Health Organization (WHO) indicates that in 2022, Germany registered approximately ... Read More
-
Global & Qatar Cancer Therapeutics Market to 2031
According to GLOBOCAN 2022, Qatar reported approximately 1,733 new cancer cases in 2022. Breast cancer was the most common, accounting for 14.3% of cases, followed by colorectal cancer at 10.5% and prostate cancer at 6.4%. The increasing number of cancer diagnoses has led to greater emphasis on adva ... Read More
-
Global & Sweden Cancer Therapeutics Market to 2031
Sweden’s cancer therapeutics market is rapidly advancing, driven by ongoing innovation in treatment methods and strong governmental support aimed at improving healthcare outcomes. Leading pharmaceutical companies like AstraZeneca, headquartered in Sweden, are playing a key role in developing cutting ... Read More
-
Global & Taiwan Cancer Therapeutics Market to 2031
The cancer therapeutics market is increasingly driven by the adoption of precision medicine and immunotherapies, with a strong emphasis on developing innovative drugs. Immuno-oncology treatments like Keytruda (pembrolizumab) and Opdivo (nivolumab) have become widely used in managing conditions such ... Read More
-
Global & India Cancer Therapeutics Market to 2031
India has experienced a marked increase in cancer cases over recent years, highlighting the urgent need for advanced treatment options. According to GLOBOCAN 2020 data, the country reported approximately 1.3 million new cancer diagnoses. Breast cancer, lung cancer, leukemia, and non-Hodgkin lymphoma ... Read More
-
Global & Greece Cancer Therapeutics Market to 2031
Greece has seen a significant rise in cancer cases, positioning the country as a key area for healthcare investment and innovation. According to the European Cancer Information System 2023, over 63,000 new cancer cases were reported in 2022, with the disease causing more than 32,000 deaths. Among me ... Read More
-
Global & Finland Cancer Therapeutics Market to 2031
In 2022, Finland reported 37,268 new cases of cancer and 13,287 deaths related to the disease, according to the Finnish Cancer Registry. Breast cancer was the most common among women, while prostate cancer predominated in men; colorectal cancer affected both genders significantly. This rising cancer ... Read More
-
Global & Luxembourg Cancer Therapeutics Market to 2031
Data from the National Cancer Registry and the European Cancer Information System reveal that Luxembourg records approximately 3,000 new cancer diagnoses annually, with around 1,100 deaths caused by the disease, accounting for about 25% of all yearly fatalities in the country. Luxembourg has become ... Read More
-
Global & Norway Cancer Therapeutics Market to 2031
Norway's universal, publicly funded healthcare system ensures equitable access to cancer treatment for all residents. The Norwegian government has consistently prioritized cancer research, with a focus on developing novel therapies and improving early detection techniques. In 2023, the Norwegian Can ... Read More
-
Global & South Korea Cancer Therapeutics Market to 2031
Cancer remains the leading cause of death in South Korea, with the number of diagnosed cases rising annually. According to the study titled Prediction of Cancer Incidence and Mortality in Korea, 2022, the country recorded approximately 274,488 new cancer cases that year. Thyroid cancer topped the li ... Read More
-
Global & Turkey Cancer Therapeutics Market to 2031
According to the Global Cancer Observatory 2021 data, approximately 233,834 individuals are diagnosed with cancer each year in Turkey, with around 126,335 cancer-related deaths annually. These figures highlight the growing need for innovative cancer treatments, including immunotherapy and targeted t ... Read More
-
Global & New Zealand Cancer Therapeutics Market to 2031
The cancer therapeutics market in New Zealand is influenced by a rising number of cancer cases, a robust healthcare infrastructure, and an increasing demand for advanced treatment options. Cancer remains a leading cause of illness and death, with lung, breast, prostate, and colorectal cancers being ... Read More
-
Global & Argentina Cancer Therapeutics Market to 2031
Data from the International Agency for Research on Cancer highlights a concerning rise in cancer cases in Argentina, with approximately 15 individuals diagnosed every hour. Annually, the country reports around 120,000 new cancer cases. According to The Global Cancer Observatory, Argentina recorded a ... Read More
-
Global & Algeria Cancer Therapeutics Market to 2031
As reported by GLOBOCAN 2022, Algeria documented approximately 64,713 new cancer cases and 35,778 cancer-related deaths in that year. In response to the growing cancer burden, the country has been actively working to enhance access to treatment and improve patient outcomes by strengthening its healt ... Read More
Research Assistance